MedTrace Logo

AVEIR Remote Care System Non-Significant Risk Study

NCT06542133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2025-04-10

No results posted yet for this study

Summary

The goal of the study is to understand the performance of the AVEIR Remote Care System in an initial patient cohort which will inform the ability to offer a remote follow-up solution to all patients implanted with Aveir LP devices.

Conditions

  • Cardiac Pacemaker
  • Cardiac Rhythm Disorder
  • Bradycardia

Interventions

DEVICE

AVEIR remote care system

In-clinic or an at-home system designed to support remote follow up in Aveir leadless pacemaker patients

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-10
Primary Completion
2024-07-12
Completion
2024-08-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06542133 on ClinicalTrials.gov